Xian-sheng Huang

Changsha, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Lipoprotein(a) in atherosclerotic cardiovascular disease and proprotein convertase subtilisin/kexin-type 9 inhibitors.

Lipoprotein(a) in atherosclerotic cardiovascular disease and proprotein convertase subtilisin/kexin-type 9 inhibitors.

Journal: Clinica chimica acta; international journal of clinical chemistry
Published: February 08, 2024

Case Report: A Mysterious Giant Thrombus in the Right Atrium in a Patient With Dilated Cardiomyopathy.

Case Report: A Mysterious Giant Thrombus in the Right Atrium in a Patient With Dilated Cardiomyopathy.

Journal: Frontiers in cardiovascular medicine
Published: May 27, 2022

Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine.

Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine.

Journal: Frontiers in pharmacology
Published: May 06, 2022

A Rare Case of Isolated Right Ventricular Non-compaction With the Novel TTN Mutation.

A Rare Case of Isolated Right Ventricular Non-compaction With the Novel TTN Mutation.

Journal: Frontiers in cardiovascular medicine
Published: December 30, 2021

Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway.

Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway.

Journal: Oncotarget
Published: August 11, 2017

Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.

Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.

Journal: PloS one
Published: April 19, 2017

Metformin ameliorates obesity-associated hypertriglyceridemia in mice partly through the apolipoprotein A5 pathway.

Metformin ameliorates obesity-associated hypertriglyceridemia in mice partly through the apolipoprotein A5 pathway.

Journal: Biochemical and biophysical research communications
Published: July 24, 2016

Statin therapy for heart failure: to prescribe or not?

Statin therapy for heart failure: to prescribe or not?

Journal: Journal of thoracic disease
Published: December 02, 2015

Inflammation Activation Contributes to Adipokine Imbalance in Patients with Acute Coronary Syndrome.

Inflammation Activation Contributes to Adipokine Imbalance in Patients with Acute Coronary Syndrome.

Journal: PloS one
Published: November 26, 2015

The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndrome.

The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndrome.

Journal: Lipids in health and disease
Published: May 31, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026